Similar Papers

Paper Title
Journal
Date
Author
PD22-05 IS PRE OPERATIVE PSMA (PROSTATE SPECIFIC MEMBRANE ANTIGEN) PET/CT A RELIABLE PREDICTOR OF PELVIC LYMPH NODE METASTASIS IN INTERMEDIATE AND HIGH RISK LOCALISED PROSTATE CANCER:A MULTI CENTRE RETROSPECTIVE ANALYSIS
Kishore Ta ... Dinesh Cherian
Journal of Urology | VOL. 209
Kishore Ta, et. al.Kishore Ta ... Dinesh Cherian
01 Apr 2023
Causes of death in intermediate- and high-risk prostate cancer treated with radiotherapy with or without androgen deprivation therapy: Analysis from two phase III trials.
Abdenour Nabid ... Luis Souhami
Journal of Clinical Oncology | VOL. 34
Abdenour Nabid, et. al.Abdenour Nabid ... Luis Souhami
10 Jan 2016
393 THE NUMBER OF PELVIC LYMPH NODES REMOVED AT RADICAL RETROPUBIC PROSTATECTOMY AFFECTS THE RATE OF NODAL INVOLVEMENT IN ALL RISK CATEGORIES OF PROSTATE CANCER
Giuseppe Campo ... Francesco Francesca
Journal of Urology | VOL. 183
Giuseppe Campo, et. al.Giuseppe Campo ... Francesco Francesca
01 Apr 2010
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer
Noelia Sanmamed ... Joelle Helou
Brachytherapy | VOL. 22
Noelia Sanmamed, et. al.Noelia Sanmamed ... Joelle Helou
20 Dec 2022
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial
Aniek E.M Schouten ... Anne M May
Journal of Clinical Oncology | VOL. -
Aniek E.M Schouten, et. al.Aniek E.M Schouten ... Anne M May
13 Jan 2025
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?
Jennifer L Crombie ... Ann S Lacasce
Journal of Clinical Oncology | VOL. -
Jennifer L Crombie, et. al.Jennifer L Crombie ... Ann S Lacasce
07 Jan 2025
Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?
Mahsoem Ali ... Geert Kazemier
Journal of Clinical Oncology | VOL. -
Mahsoem Ali, et. al.Mahsoem Ali ... Geert Kazemier
06 Jan 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study
Jacob Sands ... Luis Paz-Ares
Journal of Clinical Oncology | VOL. -
Jacob Sands, et. al.Jacob Sands ... Luis Paz-Ares
06 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.